In brief
After the introduction of vaccinations, mpox cases have notably reduced in eastern DR Congo, with healthcare workers optimistic about the progression. Nonetheless, the World Health Organization warns that the outbreak isn't over, particularly among children, as new infection rates plateau.
In a hopeful turn for the ongoing mpox outbreak in eastern Democratic Republic of Congo, healthcare providers report a significant decline in new cases since the administration of the first vaccines last month. Nurse Jackson Murhula from the Lwiro clinic revealed that the facility is currently seeing only two to three mpox cases daily, a stark contrast to earlier months when patient numbers surged to critical levels. The UN World Health Organization (WHO) has recognized this downward trend, though officials advise caution, emphasizing that it remains early to assess the full impact of vaccinations.Mpox, previously referred to as monkeypox, is a contagious viral disease that has already claimed at least 900 lives in DR Congo this year alone. This worrying toll coincides with a forthcoming meeting to evaluate whether the mpox outbreak should continue to be classified as a global public health emergency.During a recent visit to the Lwiro clinic, about an hour away from Bukavu, the BBC observed a marked shift from chaos to a more manageable situation. The facility had been overwhelmed just two months prior, with patients filling wards to capacity, but now the clinic boasts some vacant beds. Nurse Emmanuel Fikiri confirmed that such improvements are largely due to an effective vaccination program, supported by international partners.Since the launch of its vaccination initiative in October, DR Congo has received 265,000 vaccine doses, with more than 50,000 administered to individuals identified as most vulnerable in the eastern regions. However, experts have noted the concerning trend of children significantly affected by mpox, with 30% of infections occurring in this demographic. It wasn't until recently that the WHO authorized a vaccine for children, a necessary step given their role in disease transmission.While the atmosphere in Lwiro has improved, with fewer cases reported, Nurse Murhula cautioned that it is premature to declare victory against mpox. Children like three-year-old Atukuzwe Banissa are still admitted for treatment, emphasizing the ongoing risks faced by this age group. As healthcare workers encourage parents to seek medical help over traditional remedies, the clinic has seen a shift in patient behavior, allowing for improved management outcomes.Dr. Samuel Boland, who oversees mpox response efforts for the WHO, stated that the crisis is most concentrated in DR Congo, Uganda, and Rwanda, where 96% of new cases occur. While DR Congo appears to have reached a plateau, Boland warned against complacency, asserting that the potential for resurgence remains high.As vaccination efforts expand across Africa, including Nigeria and Rwanda, public health authorities remain vigilant. Dr. Jean Kaseya, head of the Africa Centres for Disease Control and Prevention, reiterated the need for sustained intervention, adequate surveillance, and enhanced laboratory capabilities to assess and respond to the outbreak's evolving nature effectively. The WHO will convene to consider further evidence related to the spread and management of mpox before determining if it is appropriate to lower the global alert status. The ongoing situation underscores the importance of continuous support in tackling contagious diseases amid fluctuating infection rates.
